Most of the cVDPVs that have been described so far share phenotypic characteristics including the capacity to induce poliomyelitis in humans and in transgenic mice expressing CD155, the human cellular receptor for PV [67,83,84,88]. The gene discussed is PVR; the disease is poliomyelitis.